<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02214537</url>
  </required_header>
  <id_info>
    <org_study_id>MADDA12201301</org_study_id>
    <nct_id>NCT02214537</nct_id>
  </id_info>
  <brief_title>Does DNA Sperm Fragmentation Affects Embryo Morphokinetic?</brief_title>
  <acronym>MACs-ESD</acronym>
  <official_title>Embryo Development Measure Depending on the DNA Sperm Fragmentation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IVI Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IVI Madrid</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The embryokinetics may be a new prognostic factor for choosing the human embryos with the
      highest implantation potential. In order to identify the factors that may affect the rate of
      embryo cleavage, there are many studies about morphokinetics and culture medium, oxygen
      tension, oocyte quality or type of medication used for ovarian stimulation. However there are
      no published data with respect to the influence of sperm DNA fragmentation in the embryo
      kinetic.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Because we donÂ´t have the necessary technology anymore
  </why_stopped>
  <start_date>February 2016</start_date>
  <completion_date type="Actual">February 2018</completion_date>
  <primary_completion_date type="Actual">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time of pronuclear appearance in hours.</measure>
    <time_frame>The mean time of appearance of pronuclei is 3.3951 hours in our patients. We are going to evaluate pronuclear appearence time in hours in our study groups</time_frame>
    <description>We want to study whether differences exist in the time of appearance of pronuclei in those embryos that derived from semen samples from the two study groups
the minimum value of the difference to be detected; we said that about 3 hours apart.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Blastocyst Time</condition>
  <condition>Pronuclear Appearance</condition>
  <condition>Pronuclear Fading</condition>
  <condition>Embryo Compaction</condition>
  <condition>Cleavage Times</condition>
  <arm_group>
    <arm_group_label>MACS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with MACS Selection</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MACS</intervention_name>
    <arm_group_label>MACS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients 36 to 38 years

          -  Fresh sample semen

          -  Minimum 6 oocytes

          -  Semen sample with at least 5 million/ml and at least 30% of progressive motile sperm.

        Exclusion Criteria:

          -  Patients younger than 36 or older than 38 years old

          -  Frozen semen sample

          -  Less tan 6 oocytes.

          -  Semen samples with less than 5 million / ml or less than 30% of motile sperm.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>36 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Manuela Alonso</last_name>
    <role>Study Director</role>
    <affiliation>IVI Madrid</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Agudo, PhD</last_name>
    <role>Study Director</role>
    <affiliation>IVI Madrid</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Testillano</last_name>
    <role>Study Chair</role>
    <affiliation>IVI Madrid</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alberto Pacheco, PhD</last_name>
    <role>Study Director</role>
    <affiliation>IVI Madrid</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IVI Madrid</name>
      <address>
        <city>Madrid</city>
        <zip>28023</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2014</study_first_submitted>
  <study_first_submitted_qc>August 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2014</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IVI Madrid</investigator_affiliation>
    <investigator_full_name>David Agudo Garcillan</investigator_full_name>
    <investigator_title>PHD</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

